Literature DB >> 12427655

Enzymatically modified nonoxidized low-density lipoprotein induces interleukin-8 in human endothelial cells: role of free fatty acids.

Prapat Suriyaphol1, Dominic Fenske, Ulrich Zähringer, Shan-Rui Han, Sucharit Bhakdi, Matthias Husmann.   

Abstract

BACKGROUND: Treatment of low-density lipoprotein (LDL) with a protease and cholesterolesterase transforms the lipoprotein to an entity that resembles lipoprotein particles in atherosclerotic lesions, which have a high content of free cholesterol, reflecting extensive de-esterification in the intima. Because de-esterification would occur beneath the endothelium, we examined the effects of enzymatically modified LDL (E-LDL) on cultured endothelial cells. METHODS AND
RESULTS: Incubation of endothelial cells with E-LDL provoked selective accumulation of interleukin (IL)-8 mRNA and production of the cytokine. Chemical analyses and depletion experiments indicated that the effect was caused by the presence of free fatty acids in the altered lipoprotein. Reconstitution studies demonstrated that the oleic and linoleic acids associated with E-LDL are particularly effective IL-8 inducers. The effects of E-LDL on endothelial cells could be abrogated with albumin.
CONCLUSION: IL-8 is required for rolling monocytes to adhere firmly to the endothelium; thus, the findings reveal a link between subendothelial entrapment of LDL, cleavage of cholesterol esters, and monocyte recruitment into the lesion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427655     DOI: 10.1161/01.cir.0000038366.11851.d0

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  4 in total

1.  Unsaturated fatty acids drive disintegrin and metalloproteinase (ADAM)-dependent cell adhesion, proliferation, and migration by modulating membrane fluidity.

Authors:  Karina Reiss; Isabell Cornelsen; Matthias Husmann; Gerald Gimpl; Sucharit Bhakdi
Journal:  J Biol Chem       Date:  2011-06-03       Impact factor: 5.157

2.  Enzymatically Modified Low-Density Lipoprotein Is Present in All Stages of Aortic Valve Sclerosis: Implications for Pathogenesis of the Disease.

Authors:  Laura Twardowski; Fei Cheng; Jens Michaelsen; Stefan Winter; Ute Hofmann; Elke Schaeffeler; Simon Müller; Maike Sonnenberg; Kristin Steuer; German Ott; Matthias Schwab; Ulrich F W Franke; Michael Torzewski
Journal:  J Am Heart Assoc       Date:  2015-10-16       Impact factor: 5.501

Review 3.  Neutrophils as a Novel Target of Modified Low-Density Lipoproteins and an Accelerator of Cardiovascular Diseases.

Authors:  Takashi Obama; Hiroyuki Itabe
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

Review 4.  Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis.

Authors:  Martina B Lorey; Katariina Öörni; Petri T Kovanen
Journal:  Front Cardiovasc Med       Date:  2022-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.